Indoco Remedies Ltd (BOM:532612)
₹ 376.45 8.55 (2.32%) Market Cap: 34.69 Bil Enterprise Value: 41.15 Bil PE Ratio: 44.57 PB Ratio: 3.06 GF Score: 79/100

Indoco Remedies Ltd at Nirmal Bang Investor Conference (Virtual) Transcript

Feb 13, 2023 / NTS GMT
Release Date Price: ₹366.8 (+0.48%)
Mitesh Shah

Good morning to everyone. On behalf of Nirmal Bang Institutional Equities, I welcome you all to this session with Indoco Remedies as a part of our investor conference. At the outset, I would like to thank the management of Indoco Remedies for giving us an opportunity to host them at our conference.

Among the senior management of Indoco Remedies, today, we have with us Ms. Aditi Panandikar, Managing Director; Mr. Sundeep Bambolkar, Joint Managing Director; and Mr. Pramod Ghorpade, CFO.

I would request the management to commence this session with some opening remarks on the business environment as it stands today, further to which we will open the floor to the investors for Q&A session. Thanks, and over to you, ma'am.

Aditi Milind Panandikar
Indoco Remedies Limited - MD & Executive Director

Yes. Good morning, everybody. I really can't make out how many people are online, but all the same, nice to interact with all of you. So coming to Indoco, as you know, 3 quarters behind us, we recently had a call after our third quarter earnings.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot